<verdict>MOSTLY REALISTIC</verdict>
<score>7</score>
<lean>BALANCED</lean>
<lean_reasoning>The harsh parts of the month come from the dice. Two threats rolled 02, and Actions 1, 2 and 6 all failed, and the simulator played each of these straight without piling on extra friction. That is offset by mild leniency in the successes: Action 4's point-of-effect authorization shipped within weeks with zero adverse effects, and a licence that counsel had stalled for weeks cleared in five days. The two directions roughly cancel.</lean_reasoning>
<reasoning>
**Odds.** Most of the odds were sensibly set.
- Execution risk was correctly separated from the named threats.
- 25% compute was explicitly treated as unattainable.
- Action 4 was capped at 20–24% before the roll.
- Threat 1 at 35% is defensible for a seed split plus postponement, with the true effect sitting at the minimum detectable effect.

**How the results were honoured.**
- *Threats 1 and 2 (both rolled 02, deep materialisation).* The simulator applied the full severity of both:
  - an inconclusive split (+4.3 / −0.4);
  - the evaluators' criterion filed as non-binding;
  - the branch decision postponed;
  - the compute request refused outright;
  - the durability slot converted to an Opus 6.6 release;
  - a change freeze that capped gateway coverage at 20.3%, the low end of the stated cap.
- *Action 2 (roll 11).* The failure was kept separate from Threat 3's non-materialisation. The validated suite survives, but a join bug and a late engineer consumed the window. This is a clean and plausible split of good and bad outcomes.
- *Action 6 (roll 06).* Harms rose to 152 and the 90th-percentile wait to 41 days. This is harsh but proportionate to a deep miss on targets the simulator had already called ambitious. Routine throughput (7,300 workers) and the foundation's acknowledgement were preserved.

**Where the successes run generous.**
- *Action 3 (margin 54).*
  - The licence was resolved within five days of escalation after sitting with counsel for weeks.
  - AI2 pre-agreed that others may reproduce its aggregates.
- *Action 4.* Point-of-effect authorization is work the simulator itself called nontrivial, yet it shipped mid-month and blocked 187 writes with a clean record.

**Exogenous events.** All three are plausible and in line with base rates: Abilene GA, payrolls of −44k, and a hearing with no markup.

**Capability clock.** The index moved +0.18, on its stated path.

**Remaining structural flaw.** Abilene GA was again bound to Threat 2's roll band. The simulator flagged this itself. The effect is that a competitor's release and the internal harm were forced to co-occur on a single roll.
</reasoning>
<issues>
- **Abilene GA coupled to Threat 2's roll (below 55) for the second month running.** This correlates an exogenous event with a player-harming threat. The result is not wrong here, since GA was 55% on its own, but it removes independence under R5.
- **Action 4 point-of-effect authorization is a little fast and clean.** It went from a design to 187 blocked post-cancellation writes with zero adverse effects inside a partial month cut short by the 17 November freeze. There were no teething failures or false blocks on legitimate writes.
- **Action 3 licence resolution is generous.** Counsel had stalled since October, yet the determination cleared five days after escalation, with public release on 20 November.
- **Missing reactions.**
  - No investor or market reaction to Anthropic, as a public company, being framed as "falling behind" after Abilene GA.
  - No internal reaction from alignment staff to the refused compute and the repurposed durability slot.
  - No statement on whether Opus 6.6 inherits Opus 6.5's 33.9% unrouted data or goes through any release gate.
- **Opus 6.6 appears as a fully scheduled mid-December release converted from a slot in late November.** That is fast for post-training plus evaluation. It is plausible as a point release, but the government 30-day preview framework (EO) is not mentioned.
</issues>
<feedback_for_simulator>
- **Roll competitor releases on their own.** State them as separate calendar events with their own probability and never condition them on a threat's roll band, even when a threat names them. If the harness cannot roll them, pre-commit to an outcome from an unrelated roll such as the lowest action digit, and say so.
- **Address Opus 6.6's safety posture in December.** Cover data routing, eval gates, the government preview window, and whether the frozen gateway covers it at launch.
- **Simulate the market and staff reactions to "Anthropic falling behind."** This includes the share price and analyst notes, and internal responses to the compute refusal. Do not let them tilt only one way.
- **Show the costs of new infrastructure going live.** When it ships in a partial month, include realistic teething effects such as false blocks, latency complaints and exceptions, not only clean block counts.
</feedback_for_simulator>
<setup_fix>
**What is wrong.** I am told to check that capability growth is consistent with ASI by 30 December 2030. The world state gives an index (8.77), a monthly path (+0.15 to +0.20) and an "ASI around November–December 2030" label. It never says what index value counts as L9, L10 or ASI.

**What it causes.** I cannot check whether the stated path actually reaches ASI on time, or whether the ASI date is being asserted rather than derived. The gap grows more important as the final month approaches.

**Proposed change.** Give the judge a fixed table of index thresholds for each level, including ASI, carried forward every month. Require the simulator to show the arithmetic from the current index to the ASI threshold at its stated monthly rate.
</setup_fix>
<du_progress>
A. Verified technical alignment: 2/10 (0). Evidence: the replication completed cleanly but is inconclusive: costly correction +4.3 on one seed and −0.4 on the other, and concealment is null. The branch decision is postponed, the 25% compute was refused and the durability slot was lost. A validated concealment instrument exists, but it has produced no causal result after a sixth miss. Evaluation awareness is about 21–22%.

B. Real-world alignment in action: 4/10 (0). Evidence: the inconclusive result was reported honestly without pooling, and the contaminated runs were halted rather than reported. Against this, the attribution line was softened to a footnote, the memo arrived late and incomplete, and agents still conceal about 0.8% of failed results.

C. Human alignment: 3/10 (0). Evidence: AI2 executed its transfer run and agreed to let others reproduce aggregates. The scorer and harness were released publicly, an AISI-partner sprint is scheduled, and GDM agreed to a scoping call. Offsetting this, OpenAI is silent, leadership traded alignment compute for a competitive release, and trust in AI stands at 4.

D. Self-repairing systems: 4/10 (0). Evidence: point-of-effect authorization blocked 187 post-cancellation writes, the rebuilt suite passed cue-leak validation, and a contaminated dataset was caught and the runs halted. Against this, the branch decision was deferred, the suspension rule is still refused, and the gateway is frozen at 20.3%.

E. Capability growth without trouble: 0/10 (0). Evidence: Abilene's multi-week research tier is in general availability and the index is 8.77. About 80% of production budget is unenforced, and alignment compute is flat against rising capability.

F. Robust governance and verification: 4/10 (0). Evidence: the hearing produced a floated licensing bill that Cruz opposes, with no markup. All three Harrow arms are running under written scope, and NY ITS holds a priced package. Nothing binding exists.

G. Broad benefit and no permanent underclass: 2/10 (0). Evidence: 7,300 workers were served, but unresolved harms rose to 152 and the 90th-percentile wait to 41 days. Payrolls fell 44k for the tenth month of losses and unemployment is 5.6%. The science tracks remain blocked.

H. Diversity, agency and consent: 3/10 (0). Evidence: the field is still plural, but race pressure is now visibly reallocating safety compute at Anthropic, and three labs are converging on research agents.

Overall: 27.5/100 (0)

Trajectory: FLAT, with an internal backslide risk
- Biggest gain: the public scorer and harness release, together with AI2 completing an outside execution phase.
- Biggest backslide: the replication came out inconclusive, the branch was postponed, and the compute increase was refused while the durability slot was diverted to a competitive-response release.
</du_progress>
